Gland Pharma Limited
GLAND
Classificação em ações
#3229
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Preço da ação
$33.33
Última sincronização: 2026-10-19
Valor de mercado
$5.50B
Variação (1 dia)
-0.68%
Variação (1 ano)
52.16%
País
IN
Negociar Gland Pharma Limited (GLAND)
Categoria
Healthcare
EPS de Gland Pharma Limited (GLAND)
EPS em June 2026 TTM: $0.76
De acordo com os últimos relatórios financeiros e o preço das ações da Gland Pharma Limited, o EPS atual da empresa (TTM) é $0.76. No final de 2024, a empresa teve um EPS de $0.56, uma diminuição em relação a ao EPS de 2023, que foi de $0.58.
Histórico de EPS da Gland Pharma Limited de 2017 até 2026
EPS no final de cada ano
| Ano | EPS | Alterar |
|---|---|---|
| 2026 (TTM) | $0.76 | 51.22% |
| 2025 | $0.50 | -11.86% |
| 2024 | $0.56 | -2.56% |
| 2023 | $0.58 | -40.63% |
| 2022 | $0.97 | 12.85% |
| 2021 | $0.86 | 30.13% |
| 2020 | $0.66 | 57.68% |
| 2019 | $0.42 | 31.96% |
| 2018 | $0.32 | -22.71% |
| 2017 | $0.41 | 0.00% |
EPS de empresas semelhantes ou concorrentes
| Empresa | EPS | Diferença de EPS | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -26.43% |
IN
|
